XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated Other comprehensive income
Accumulated deficit
Beginning balance (in shares) at Sep. 30, 2020   45,083      
Beginning balance at Sep. 30, 2020 $ 336,262 $ 0 $ 794,630 $ 87 $ (458,455)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in public offering, net of underwriting discounts and commissions and offering expenses (in shares)   3,136      
Issuance of common stock in public offering, net of underwriting discounts and commissions and offering expenses 323,887   323,887    
Net exercise of stock warrants (in shares)   22      
Vesting of restricted stock units (in shares)   121      
Exercise of stock options (in shares)   497      
Exercise of stock options 9,137   9,137    
Issuance of shares under the employee stock purchase plan (in shares)   49      
Issuance of shares under the employee stock purchase plan 2,787   2,787    
Repurchases of early exercised stock options (in shares)   (2)      
Repurchases of common stock for income tax withholding (in shares)   (46)      
Repurchases of common stock for income tax withholding (5,751)   (5,751)    
Stock-based compensation 18,575   18,575    
Other comprehensive income 103     103  
Net loss (70,819)       (70,819)
Ending balance (in shares) at Mar. 31, 2021   48,860      
Ending balance at Mar. 31, 2021 614,181 $ 0 1,143,265 190 (529,274)
Beginning balance (in shares) at Dec. 31, 2020   48,616      
Beginning balance at Dec. 31, 2020 637,952 $ 0 1,129,165 142 (491,355)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Public offering expense adjustment 36   36    
Vesting of restricted stock units (in shares)   67      
Exercise of stock options (in shares)   152      
Exercise of stock options 3,066   3,066    
Issuance of shares under the employee stock purchase plan (in shares)   49      
Issuance of shares under the employee stock purchase plan 2,787   2,787    
Repurchases of early exercised stock options (in shares)   (2)      
Repurchases of common stock for income tax withholding (in shares)   (22)      
Repurchases of common stock for income tax withholding (3,341)   (3,341)    
Stock-based compensation 11,552   11,552    
Other comprehensive income 48     48  
Net loss (37,919)       (37,919)
Ending balance (in shares) at Mar. 31, 2021   48,860      
Ending balance at Mar. 31, 2021 614,181 $ 0 1,143,265 190 (529,274)
Beginning balance (in shares) at Sep. 30, 2021   49,499      
Beginning balance at Sep. 30, 2021 580,821 $ 0 1,190,828 546 (610,553)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in public offering, net of underwriting discounts and commissions and offering expenses (in shares)   5,227      
Issuance of common stock in public offering, net of underwriting discounts and commissions and offering expenses 269,818   269,818    
Vesting of restricted stock units (in shares)   163      
Exercise of stock options (in shares)   368      
Exercise of stock options 3,934   3,934    
Issuance of shares under the employee stock purchase plan (in shares)   50      
Issuance of shares under the employee stock purchase plan 2,395   2,395    
Repurchases of common stock for income tax withholding (in shares)   (62)      
Repurchases of common stock for income tax withholding (4,050)   (4,050)    
Issuance of shares from business acquisition (in shares)   989      
Issuance of shares from business acquisition 77,122   77,122    
Stock-based compensation 40,573   40,573    
Other comprehensive income (1,021)     (1,021)  
Net loss (106,231)       (106,231)
Ending balance (in shares) at Mar. 31, 2022   56,234      
Ending balance at Mar. 31, 2022 863,361 $ 0 1,580,620 (475) (716,784)
Beginning balance (in shares) at Dec. 31, 2021   50,735      
Beginning balance at Dec. 31, 2021 626,178 $ 0 1,281,931 363 (656,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in public offering, net of underwriting discounts and commissions and offering expenses (in shares)   5,227      
Issuance of common stock in public offering, net of underwriting discounts and commissions and offering expenses 269,818   269,818    
Vesting of restricted stock units (in shares)   100      
Exercise of stock options (in shares)   100      
Exercise of stock options 896   896    
Issuance of shares under the employee stock purchase plan (in shares)   50      
Issuance of shares under the employee stock purchase plan 2,395   2,395    
Repurchases of common stock for income tax withholding (in shares)   (38)      
Repurchases of common stock for income tax withholding (1,493)   (1,493)    
Issuance of shares from business acquisition (in shares)   60      
Issuance of shares from business acquisition 4,608   4,608    
Stock-based compensation 22,465   22,465    
Other comprehensive income (838)     (838)  
Net loss (60,668)       (60,668)
Ending balance (in shares) at Mar. 31, 2022   56,234      
Ending balance at Mar. 31, 2022 $ 863,361 $ 0 $ 1,580,620 $ (475) $ (716,784)